APOE and atherosclerosis: Also, RAGE deletion [28] or blockade [using a soluble AGE receptor (sRAGE)] suppressed the development of atherosclerotic lesions and stabilized established atherosclerosis in diabetic ApoE-/- mice [26, 32].